Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
about
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention.Troponin in Cardiovascular Disease Prevention: Updates and Future Direction.Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis.Plasma NT-proBNP mirrors the deleterious cardiovascular and renal continuum in hypertension.Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trialBiomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study)
P2860
Q37556404-BADD5877-9172-4904-B44A-750D3C222338Q38734398-BBEBAF1A-60DD-41E7-88D0-F8AC21C8C1A8Q38935475-984DE3B2-3193-4AF5-813D-827BC4E67377Q47720932-80D28587-0BB3-45B8-AD12-AB481F9C8C36Q48356073-66308511-0606-4EA4-B2CB-926DAFB8DA4CQ48366139-CCF38038-1743-4AD7-9F45-EEB273AA2822Q48405149-BE308D6E-44CF-48B8-B83C-02E82B4AE30DQ58040909-7C4537CD-BF44-494F-8BDE-15B0E8D11EF7Q58727369-91E3F38E-3C72-498B-BAE8-727DD5CAD561
P2860
Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@en
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@nl
type
label
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@en
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@nl
prefLabel
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@en
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@nl
P2093
P2860
P356
P1476
Risk stratification in stable ...... ro-B-type natriuretic peptide.
@en
P2093
CLARICOR Trial Group
Erik Kjøller
Gorm Boje Jensen
Hans Jørn Kolmos
Jens Kastrup
Jens P Gøtze
Jørgen Fischer Hansen
Jørgen Hilden
Per Hildebrandt
Per Winkel
P2860
P304
P356
10.1177/2047487313492099
P577
2013-05-30T00:00:00Z